Lafarge Canada targets energy reductions in Edmonton 17 May 2021
Lafarge Canada Inc has participated in three Edmonton City initiatives, demonstrating how local community and businesses can underpin an energy transition. The three initiatives are: Corporate Climate Leaders, Building Energy Retrofit Accelerator Rebate, and Energy Benchmarking.
As a part of the endeavour, Lafarge measured the energy consumption (natural gas and electricity) of its participating buildings with over 400 local buildings. From there, and with the help of a rebate from the Building Energy Retrofit Accelerator programme, the producer completed a lighting conversion project at its Winterburn shop. The site reduced energy consumption by 33 per cent and increased lighting by 1400 per cent.
Scientists identify receptor in cells that could be key to preventing cancer drug-induced hearing loss
University of Alberta scientists have identified a receptor in cells that could be key to preventing permanent hearing loss in childhood cancer survivors who are being treated with the drug cisplatin. The researchers believe by inhibiting the receptor, they may be able to eliminate toxic side-effects from the drug that cause the hearing loss.
Cisplatin is an incredibly effective chemotherapeutic when it comes to treating solid tumors in children, contributing to an 80 per cent overall survival rate over five years, according to U of A researcher Amit Bhavsar, an assistant professor in the Department of Medical Microbiology & Immunology. The problem has always been with the side-effects. Nearly 100 per cent of patients who receive higher doses of cisplatin show some degree of permanent hearing loss. The ability to prevent this side-effect would dramatically improve the quality of l
E-Mail
IMAGE: University of Alberta researcher Amit Bhavsar is leading a team that has identified a receptor in cells that could be key to preventing permanent hearing loss in childhood cancer survivors. view more
Credit: William Au
University of Alberta scientists have identified a receptor in cells that could be key to preventing permanent hearing loss in childhood cancer survivors who are being treated with the drug cisplatin. The researchers believe by inhibiting the receptor, they may be able to eliminate toxic side-effects from the drug that cause the hearing loss.
Cisplatin is an incredibly effective chemotherapeutic when it comes to treating solid tumours in children, contributing to an 80 per cent overall survival rate over five years, according to U of A researcher Amit Bhavsar, an assistant professor in the Department of Medical Microbiology & Immunology. The problem has always been with the side-effects. Nearly 100 per cent of patients who receive higher
Tehillah Worship. (Supplied)
Article continues below advertisement ↴
A worship band out of Calgary is sharing their songs of celebration and joy with the church of Canada.
Michael Larson is the Worship Pastor at First Assembly Church in Calgary, Alberta, and leads the group called Tehillah Worship. He s also a songwriter/singer. Tehillah is actually one of the Hebrew words for praise. When the original founders of Tehillah formed this gathering, a young adult-focused gathering that happened on Monday nights, they thought it would be a good name. It s been a community for 30 years.
Larson has been leading Tehillah Worship for the past ten years.
Tehillah Worship. (Supplied)
Article continues below advertisement ↴
A worship band out of Calgary is sharing their songs of celebration and joy with the church of Canada.
Michael Larson is the Worship Pastor at First Assembly Church in Calgary, Alberta, and leads the group called Tehillah Worship. He s also a songwriter/singer. Tehillah is actually one of the Hebrew words for praise. When the original founders of Tehillah formed this gathering, a young adult-focused gathering that happened on Monday nights, they thought it would be a good name. It s been a community for 30 years.
Larson has been leading Tehillah Worship for the past ten years.